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Trans-complementationSendai virus (SeV) HN protein is dispensable for virus particle production. HN incorporation into virions
strictly depends on a cytoplasmic domain SYWST motif. HNAFYKD, with SYWST replaced with the analogous
sequence of measles virus (MeV) H (AFYKD), is not incorporated in virus particles produced by LLCMK2 cells,
although it is normally expressed at the plasma membrane. Unlike HNSYWST, HNAFYKD is not internalized
to late endosomes, raising the possibility that HN internalization is required for uptake into virus particles.
Various mosaic MeV-H containing increasing amounts of the SeV-HN all failed to be taken up in SeV virions.
However, when co-expressed with HNAFYKD these MeV-H chimera induced HNAFYKD uptake into virions
showing that internalization is not a prerequisite for HN uptake into particles. We propose that HN
incorporation in virus particles requires ﬁrst neutralization by HN of a putative inhibitor of infectious particle
formation.ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
In the vast majority of the cases, the contamination of new hosts
occurs via transmission of infectious virus particles. Virus particle
production during infection occurs via the orderly gathering of the
different structural components, after their accumulation at strategic
locations of the infected cell, to levels consistent with their interaction
properties. For enveloped viruses, their glycoproteins must congregate
at patches on a cellular membrane, generally by contacting the viral
matrix protein that carpets the cytoplasmic side of themembrane. These
modiﬁed cellular membranes then interact with the viral cores through
the matrix protein and/or the cytoplasmic tails of the glycoproteins.
Viral buds eventually form and detach from the membrane with the
help the cellular vesiculation machinery, releasing new virus particles.
This processmay ormaynot require all the viral structural proteins,
and the interactions between the viral constituents may be more or
less speciﬁc. For example, the ability of HIV-Gag to bud and form
particles without the Env glycoprotein is well documented (Freed,
1998). Similarly, the efﬁcient incorporation of the vesicular stomatitis
virus (VSV) G glycoprotein in these HIV-Gag-containing particles is a
good example of ﬂexible requirements for virus particle formation(Bartz and Vodicka, 1997). This ﬂexibility, however, may be a feature of
retrovirusGag coupledwith a viral glycoprotein (VSV-G) that contains a
short cytoplasmic domain, which appears to be poorly selective.
Pseudo-typing retroviruses with Paramyxoviruses glycoproteins
appears more demanding, since the cytoplasmic portion of the
heterologous proteins has usually to be deleted, or replaced with that
of the homologous proteins (Funke et al., 2009 and references therein).
Pseudo-typing negative strand virus (NSV) particles with foreign
glycoproteins led to a whole range of observations. In general, the
cytoplasmic domains play a role in the incorporation of the glycoprotein
in the virus particle and in the formation of the virus particle.
Replacement of human parainﬂuenza type 3 (HPIV3) HN and F with
the corresponding proteins of human parainﬂuenza type 1 (HPIV1) led
to recovery of fully viable viruses (Tao et al., 1998). This contrastedwith
the failure of replacing HPIV3 glycoproteins with those of human
parainﬂuenza type 2 (HPIV2). In this latter case, HPIV3 trans-membrane
and cytoplasmic domainswere compulsory to obtain chimerical viruses
(Tao et al., 2000). Similarly, incorporation of Newcastle disease virus
(NDV) HN into SeV particle required the presence of SeV-HN
cytoplasmic domain (Takimoto et al., 1998). Inﬂuenza virus HA
containing a foreign cytoplasmic tail, as well as foreign proteins, failed
to incorporate into inﬂuenza virions (Naim and Roth, 1993). Again,
incorporation of inﬂuenza HA and NA, or of measles H and cellular CD4,
in VSV particles was relatively efﬁcient (Kretzschmar et al., 1996;
Schnell et al., 1998). With the exception of VSV, it thus appears that the
440 A.-S. Gosselin-Grenet et al. / Virology 405 (2010) 439–447incorporation of NSV glycoproteins in progeny virions relies on speciﬁc
signals present in the homologous glycoproteins. Another feature of the
NSV particle formation is the very inefﬁcient budding of the viral
nucleocapsid in the absence of the viral envelope proteins (for a review,
see (Lamb and Parks, 2007).
Sendai virus, the prototype of the Paramyxovirus family, Respiro-
virus genus, contains two surface glycoproteins: the hemagglutinin-
neuraminidase (HN) type II glycoprotein of 576 aa that binds to the
cellular receptor and the fusion (F) type I glycoprotein of 565 aa that
fuses the viral envelope and cellular membrane at the site of entry. HNFig. 1. Primary requirements for virus particle production. (A) Schematic outlines of recombi
M, F, and HN genes harboring a short nucleotide sequence derived from the green ﬂuorescent
transcription start and stop signals have been omitted. LLCMK2-LV-siGFP or -LV-NGFR cells w
six hours post-infection, the cells and cell supernatants were collected and characterized (
LLCMK2-LV-siGFP extracts (siRNA− and +, respectively) infected with the respective vir
supernatant of the infected cells listed above. (D, E) The protein band signals observed in (B
suppression and of viral particle production is shown as percentage of the values obtained in
and 8 (rSeV-F/HN-gfpt).and F form, respectively, spikes of tetramers and trimers that protrude
from the viral envelope and plasma membrane (PM). The matrix (M)
protein carpets the inner face of the viral envelope and acts as a scaffold
that bridges the envelope and the particle core [the nucleocapsid (NC)
representing the viral genome]. F andHNcondense in patches after they
interact with the layer of M. By electron microscopy, the viral
nucleocapsids can be seen aligned underneath the portion of the PM
modiﬁed by F, HN, and M (Compans et al., 1966). This concentration of
the viral components induces the curvature of the PM and drives the
formationof a budcontaining the viral nucleocapsids, a process inwhichnant SeV genome structural features. The genomes are portrayed (not to scale) with the
protein gene (gfpt), serving as target for the cognate siRNA. For simplicity, non-relevant
ere infected with rSeVs-gfpt described in (A), at a multiplicity of infection of 3. Thirty-
see Materials and methods). (B) Western blot analysis of the of LLCMK2-LV-NGFR or
uses listed above. (C) Western blot analysis of virus particle pellets derived from the
) and (C) were quantiﬁed as described in Materials and methods. The extent of protein
the control cells. (D) Graph related to lanes 1–6. (E) Same as in (D) but related to lanes 7
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eventually pinches off and a neo-formed particle is now visible on the
cell surface. Its release depends on the action of the HN neuraminidase
(for a review, see Takimoto and Portner, 2004).
It has been known for some time that SeV particles lacking HN can
be produced (Portner et al., 1975; Stricker and Roux, 1991), what
suggests that HN is not required in this process. Nevertheless,
truncation of the cytoplasmic domain of HN from 35 to 7aa reduced
virus particle formation (20–30 fold, Fouillot-Coriou and Roux, 2000).
Moreover, an HN cytoplasmic domain pentapeptide (10SYWST14) was
found to be essential for HN incorporation in virus particles, since its
removal, or its substitutionwith the corresponding peptide of measles
virus H (10AFYKD14, creating HNAFYKD), resulted in normal virus
particle production lacking HN (Takimoto et al., 1998; Fouillot-Coriou
and Roux, 2000). Interestingly, the absence of HNAFYKD incorporation
appeared to be cell-type dependent, since virus-carrying HNAFYKD
could be produced in embryonated chicken eggs (Fouillot-Coriou and
Roux, 2000), and certain clones of BSR cells allowedHNAFYKD uptake in
virus particles (unpublished), in contrast to LLCMK2 cells that exhibit
a strong restriction (this study).
This paper reports on the basic requirements for SeV particle
production in the context of an infection, and the mechanism of HN
incorporation into virus particles is also investigated. The route of HN
into virus particle is followed, and the importance of the SYWSTmotif is
assessed. We conﬁrm the dispensability of HN for virus particle
production, although new evidence suggests that F and HN act
synergistically in the process. We further show that the SYWST motif
is necessary but not sufﬁcient for incorporation in virus particles, and
that expression of theMeV-H protein containing the SYWST in trans can
restore incorporation of the mutated HNAFYKD. We propose that HN,
through its SYWST, plays an as yet undescribed role in the SeV life cycle.Fig. 2. Features of the SeV-HN glycoprotein as expressed in rSeV-HN and in rSeV-HNAFYKD
infections. (A) Schematic representation of the HA-tagged wild-type HN (HN) and its
variant HNAFYKD showing the replacement of the SYWST motif by AFYKD. (B) LLCMK2
and BSRT7 were infected with the two recombinant viruses and radioactively labeled
with 35S-methionine and cysteine as described in Materials and methods. Thirty-six
and twenty-four hours, respectively, post-infection, two-sixths of the virus pellets
recovered from the cell supernatant were directly resuspended in SDS–PAGE buffer
and analyzed by PAGE. Virus pellets recovered from 1 ml of infected allantoic ﬂuid
collected from 9-day-old embryonated chicken eggs were processed and analyzed
similarly (Coomassie blue staining). (C) 35S-labeled (as in B) LLCMK2 cell extracts and
virus particle pellets (4/6th) were disrupted in RIPA buffer and processed through
immune precipitations using anti-HA antibody. Immunoprecipitates were analyzed
by PAGE and revealed as described in Materials and methods.Results
Basic requirement for Sendai virus particle production
To globally assess the basic requirements of SeV particle formation,
virus recombinants were prepared carrying a short sequence derived
from the green ﬂuorescent protein (GFP) gene (gfpt) in the 3′
untranslated regions of the M, F, HN, or F and HN genes (Fig. 1A). This
gfpt sequence was a target for siRNA constitutively expressed in a BHK
cell line (Mottet-Osman et al., 2007). The rSeVs exhibited wild-type
phenotypes in regular cell lines. Upon infection of the siRNA-expressing
cells, however, the targeted gene products were suppressed. Fig. 1B
shows the extent of their suppression. Suppressionwasexpressed as the
value of the suppressed protein divided by that of N, versus that in the
control cells. Suppression was in all cases close to 90% (Fig. 1D and E).
Fig. 1C shows the levels of the virus particles produced, as estimated by
quantifying N protein normalized to that in the corresponding cellular
extract, and further normalized to the virus production in the control
cells (taken as 100%). As expected, suppression of M resulted in a
signiﬁcantdecrease in virus particle production (80%; Fig. 1C, lane 2, and
D), conﬁrming its role as the central organizer of virus particle assembly.
As also expected, HN suppression by itself had little or no effect on virus
production (Fig. 1C, lane 6, andD). The limited effect of F suppression on
virus particle production (Fig. 1C, lane 4, and D) was somewhat
surprising, because we previously found that cytoplasmic tail trunca-
tions of F led to the complete loss of budding (Fouillot-Coriou and Roux,
2000). Here a decrease in virus production of about 65%wasobserved in
conditions where F suppression was very efﬁcient (N90%). However,
whenHN and Fwere simultaneously suppressed (Fig. 1C, lane 8, and E),
we unexpectedly found that virtually all virus production (∼95%) was
lost, even though HN suppression by itself has no effect. These latter
results suggest that HN does play a role in virus particle production,
especially when F is diminished.HN's fate at the plasma membrane
HN uptake in virions strictly depends on the cytoplasmic domain
SYWSTmotif. Nevertheless, mutation of this motif, or the suppression
of the whole protein, is neutral for virion production (Fouillot-Coriou
and Roux, 2000; Fig. 2). Furthermore, (i) the almost complete
truncation of its cytoplasmic domain signiﬁcantly decreases virion
production (Fouillot-Coriou and Roux, 2000), and (ii) HN suppression,
concomitantwith that of the F protein, appears to further reduce virion
production (Fig. 1). To shed light on these seemingly paradoxical
phenotypic features, we set up two lines of research.We compared the
fates of wt HNSYWST and mutant HNAFYKD. We also prepared recombi-
nant MeV-H proteins carrying SeV-HN sequences and followed their
ability to be incorporated in SeV particles.
The compositions of rSeV-HN and rSeV-HNAFKYD viruses grown in
LLCMK2 and BSRT7 cells or in chicken embryos were ﬁrst compared
(Fig. 2). Egg grown viruses contained similar amount of HN protein
(Fig. 2B), consistent with the fact that rSeV-HNAFKYD viral stocks
exhibited infectivity values comparable to that of rSeV-HNs (Fouillot-
Coriou andRoux, 2000). A similar result (as far as protein composition)
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grown viruses, however, very clearly conﬁrmed the inability of
HNAFKYD to be incorporated in virus particles (as reported before in
Fouillot-Coriou and Roux, 2000). The lack of incorporation of HNAFKYD
in LLCMK2 grown virus was observed despite its presence at high
levels in the infected cell extracts (Fig. 2C). Moreover, HNAFKYD was
previously found in the same proportion as the wt protein in
association with rafts (Gosselin-Grenet et al., 2006) and at the cell
surface (Fouillot-Coriou and Roux, 2000). These observations, more
than conﬁrming the dispensability of HN for SeV particle production
and the role of the SWYST motif in HN uptake in virus particles, also
support the cell-type dependency of the HNAFKYD phenotype.
We next compared the fate of two HN proteins expressed at the
LLCMK2 cell surface. As in both viruses, HN was tagged with an HA
epitope (Fig. 2A), anti-HA antibodies were added to infected cells
incubated at 4 °C. These cells were then incubated at 37 °C, and
subsequently treated with an acid salt buffer (AWB, see Materials and
methods) to remove the antibodies still attached to HN at the cell
surface. Cells were then ﬁxed, permeabilized, and incubated with an
FITC-tagged secondary antibody. Fig. 3A shows that after antibody
adsorption at 4 °C (without an acid wash, AWB−), both rSeV-HN andFig. 3. Internalization of surface expressed HN. (A) Regular LLCMK-2 cells grown on glass co
post-infection, the cells were washed twice with PBS and incubated for 30 min on melting ic
then washed twice with PBS (AWB−) or with an acid wash buffer (AWB+) and either direc
regular medium before ﬁxation. Fixed cells were then permeabilized and incubated with g
infection, the cells were washed twice with PBS and incubated for 30 min on melting ice w
directly ﬁxed (time 0′) or further incubated at 37 °C (time 15′ and 60′) in regular medium. Th
then permeabilized. After permeabilization, goat anti-mouse antibodies coupled to Alexa 5SeV-HNAFYKD infected cells exhibited surface ﬂuorescence, conﬁrming
that both proteins are expressed at the cell surface (Fig. 4A, time 0′,
AWB−). Note thatwhen the cells are treatedwith an acidwash, the cell
surface staining is efﬁciently removed (AWB+, time 0′). After 15-min
and 60-min, 37 °C incubation and acid wash treatment (AWB+) and
permeabilization of the cells, the ﬂuorescence no longer decorated the
cell contours but appeared as dots within the cells (no ﬂuorescence in
the absence of permeabilization, not shown). This dotted ﬂuorescence
was not seen in the rSeV-HNAFYKD cells. The experiment was repeated
using a slightly different protocol (Fig. 3B). At time 0′, anti-HA antibodies
were added to the cells and sampleswere incubated at 37 °C. At different
timepoints, the cellswereﬁxedanda secondaryantibody coupled toFITC
was ﬁrst added. Cells were then permeabilized and the same secondary
antibody coupled with rhodamine was added. Fig. 3B shows again that
part of the HN bound to its speciﬁc antibody at the cell surface (FITC
staining, time 0′) was found later inside the cells coupled with the
rhodamine-tagged secondary antibody (time 15′ and 60′). Again,
HNAFYKD did not show evidence of internalization during the time course
of these experiments. These observations demonstrate that HNAFYKD, in
contrast toHN,wasnot internalized fromthe cell surface. InternalizedHN
was further shown to co-localize with lysobisphosphatidic acid (LBPA),verslips were mock treated or infected with rSeV-HN or rSeV-HNAFYKD. Thirty-six hours
e with mouse anti-HA antibodies, as described in Materials and methods. The cells were
tly ﬁxed (time 0′) or further incubated at 37 °C for 15 and 60 min (time 15′ and 60′) in
oat anti-mouse antibody coupled to FITC. (B) Infected as in (A). Thirty-six hours post-
ith mouse anti-HA antibodies. The cells were then washed twice with PBS and either
e cells were then ﬁxed, incubated with goat anti-mouse antibodies coupled to FITC, and
68 was ﬁnally added. Red bar: 20 μm.
Fig. 4. Localization of HNwt in the endocytic pathway. As in Fig. 3B, except that the
primary anti-HA antibody was from rat. After further 37 °C incubation (30′), the cells
were ﬁxed, permeabilized, and incubated with mouse anti-LBPA antibodies. Finally the
cells were treated with anti-rat IgG antibodies coupled to rhodamine and anti-mouse
IgG antibodies coupled to FITC.
Fig. 5. Fate of cell surface expressed HN. Regular LLCMK-2 cell samples, grown in 3-cm diam
were washed twice with PBS and biotinylated as described in Materials and methods. (A) Ce
the end of incubation, virus particles and cellular extracts were incubated with streptavidin b
orα-FSDS antibodies to detect HN and F, respectively. (B) SeV-HN-infected cells were biotiny
before treatment or absence of treatment with de-biotinylating buffer (−/+ DTT). Finally t
particles and cellular extracts were analyzed as in A (see text for explanations). (C) The wes
experiments) were quantiﬁed to evaluate the fraction of surface biotinylated HN ending up i
100 (lane 1, B). Total on VP: fraction of biotinylated HN scored in virus particles after 3 h of in
4 and lane 2, B). Internalized on VP: fraction of internalized HN found in virus particles (lan
illustrating the treatment of each numbered sample shown in (B). Sample 1 was analyzed d
37 °C (3, 4) with 2 and 4 treated with DT, etc.
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Fig. 4, almost all the major dots of internalized HN coincide with
endosomal dots (see examples shown by white arrowheads), whereas
some of the endosomal dotswere not superimposed over HN dots (thin
white arrows). Thus, at least some of the internalizedHN is found in late
endosomes. As expected, no internalization dots were visible in SeV-
HNAFYKD infected cells.HN en route to virus particles
HN internalization from the PM represents a point at which the wt
protein's fate diverges from that of HNAFYKD. To further investigate the
signiﬁcance of this pathway for virion production, the infected cell
surface was biotinylated. The biotinylated cells were then incubated
for increasing periods of time, and virus was puriﬁed from the
supernatants. Fig. 5A shows the incorporation of biotinylated SeV
glycoproteins into virus particles. As expected, HNAFYKD is normally
biotinylated at the cell surface but excluded from the virus particles.
About10%of the biotinylatedHNwas incorporatedduring theﬁrst hour,
and this amountwasnot increasedwith further incubation [Fig. 5A;note
that 7.5-foldmorematerialwasused to analyze virus particles (VP) than
cell extracts]. This degree of incorporation and its kinetics are in the
range of that observed following 35S-methionine pulse-chaseeter PD, were infected with rSeV-HN or SeV-HNAFYKD, and 20 h post-infection, the cells
ll samples were further incubated for increasing periods of time at 37 °C as indicated. At
eads to recover the biotinylated proteins that were further immunoblotted using α-HA
lated as in (A). They were then incubated at 4 °C or 37 °C for 30 min (−/+ endocytosis)
he cell samples were further incubated at 37 °C for 3 h before harvest. In the end, virus
tern blots presented in B (plus similar results obtained from at least three independent
n virus particles. Total on cell surface: amount of biotinylated HN at the surface taken as
cubation at 37 °C (lane 6, B). Internalized: fraction of biotinylated HN internalized (lane
e 7 and lane 5, B). (D) Schematic outline of the experiments presented in (B) and (C)
irectly after biotinylation. Samples 2, 3, and 4 were incubated for 30 min at 4 °C (2) or
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not signiﬁcantly alter HN properties. Note that F was found in virus
particles in both infections. Next, the fate of the internalized HN was
assessed. For this, biotinylationwas followed by30min at 37 °C to allow
internalization (Fig. 5B, lane 1, and D). Surface biotinwas then removed
by cell incubation in a DTT-reducing buffer (lane 2), and the fraction of
internalized HN (cell associated and resistant to reducing conditions)
was estimated (lane 4). After a further 3 h at 37 °C, virus particles in the
supernatant of the cells treatedwith the reducing buffer were collected,
to determine the fraction of internalized HN recovered in virus particles
(lane 7). Lanes 3 and 6 represent the values of biotinylated HN found,
respectively, as cell associated after the 30-min incubation at 37 °C [total
(lane1)minus that thatwas shed into virus particles during that period]
and in virus particles if no reducing treatment is applied. The experi-
ment is complicated by the inability to completely reverse biotinyla-
tion after the 30-min incubation at 4 °C, where internalization should
not occur (lane 2). Thus, residual biotinylated HN (lane 2) is a
background subtracted from the internalized HN, i.e., HN resistant to
de-biotinylation after a 30-min incubation at 37 °C (lane 4). This
biotinylated HN resistant to reduction was also found in virus particles
(lane 5) andwas subtracted from the value in lane 7. In thismanner, we
derived the fraction of HN that is internalized from the cell surface, and
the fraction of this internalized HNending up in virus particles (Fig. 5C).
The vast majority (∼90%) of cell surface HN is stable at the cell surface
for the duration of the experiment. The fractions directly targeted to
virus particles and to late endosomes are about the same (∼5%). From
the internalized fraction, about 1/5th ended up in virus particles. Thus,
internalized HN represents a minor fraction of the protein incorporated
in virus particles, suggesting that internalization may have another
purpose than that of setting the virus particle composition.Fig. 6. Schematic representation of the measles virus H glycoprotein and variants. SeV-
HN and SeV-HN
AFYKD
, as in Fig. 2. Measles virus H glycoprotein (MeV-H) was modiﬁed
to harbor the SeV-HN SWYST motif in place of the original AFYKD sequence (MeV-
H
SYWST
), the SeV-HN cytoplasmic domain (MeV-H
CD
), and the SeV-HN CD and trans-
membrane domain (MeV-H
CD/TM
). The genes for these MeV-H glycoproteins were
inserted in SeV minigenomes as described in Materials and methods and expressed in
the context of SeV infections.Signiﬁcance of the SYWST motif for protein uptake into virus particle
MeV-H, like SeV-HN, binds the cell surface receptor and is also a type
II glycoprotein (617 aa,with anN-ter cytoplasmic domain, CD), but these
proteins share almost no homology (14% identity). Different variants of
MeV-H, which normally harbors 10AFYKD14 in place of the SeV-SWYST
motif, were prepared (Fig. 6) and inserted in SeV minigenomes, to
investigate the role of the SYWST motif in uptake into virus particles.
Co-infection with helper SeV provided the minigenomes with all the
functions required for their transcription, replication, and virus particle
formation (Mottet et al., 1996). Mixed SeV stocks (containing
minigenomes and helper genomes) were prepared so that each MeV-
H could be expressed in the context of SeV infection. LLCMK2were then
infectedwith thesemixed stocks, usingMeV-Edmonston-infected Vero
cells as a control. After 35S-metabolic labeling, the infected cells and
released virus particleswere collected and analyzed. The different virus
stocks produced similar levels of infection (Fig. 7A, Total, SeV-N) and
the various MeV-H proteins were expressed in the cells (Fig. 7A, Total,
MeV-H) and at the cell surface (Fig. 7A, Surface). Analysis of the virus
particles produced revealed no interference due to the expression of
the MeV-H proteins (Fig. 7B, Total). However, there was also no
evidence that any of the MeV-H proteins were incorporated into SeV
particles, as conﬁrmed by the absence of visible protein bands in
immunoprecipitates obtained using monoclonal α-MeV-H. Note that
MeV-H could be precipitated from a supernatant of MeV-infected Vero
cells, in which MeV particles were found in amounts corresponding to
SeVs. It therefore appears that presence of SYWST alone, or of SeV-HN
CD and TM, is insufﬁcient for MeV-H uptake into SeV particles.Fig. 7. Expression of the MeV-H proteins in the context of rSeV-HN infections. LLCMK2
cells were infected with SeV or the rSeV-HN mixed virus stocks harboring minigenomes
expressing the variousMeV-H proteins. Vero cells were infectedwith Edmonstonmeasles
virus. From 16 h post-infection, the infected cells were labeled with 35S-methionine and
cysteine, and at 36 h post-infection the cells were harvested and the virus in the
supernatants were collected. (A) Samples of infected cells were either treated for total
immune precipitations using anti-SeV-N or anti-H antibodies (Total) or used to perform a
surface immune precipitation using the anti-H antibodies (Surface). The immune
precipitates were analyzed by PAGE and revealed by autoradiography. (B) The virus
particle pellets were either directly resuspended in SDS–PAGE buffer and analyzed by
PAGE or disrupted to perform immune precipitations using anti-SeV-N or anti-MeV-H
antibodies. On the right side, MeV (M) or SeV (S) viral proteins are identiﬁed.
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simply out-competes the hybrid MeV-H proteins for incorporation into
the presumably crowded SeV assembly complex. To examine this
possibility, wemadeuse of rSeV-HNAFYKD virus as a helper and prepared
mixedvirus stocks containing the sameminigenomes.Wereasoned that
since HNAFYKD is likely excluded from the assembly complex after
infection of LLCMK2, the competition for space would be relieved, and
the virus particles produced would now contain some of the MeV-H
variants. SeV-HNAFYKD was expressed normally in cells infected with
these mixed virus stocks, at levels corresponding to that of a wt SeV
infection (Fig. 8A), as were the various MeV-H proteins (Fig. 8A, lanes
2–5). 35S-virusparticle patterns are shown in Fig. 8B (Total). Lanes 1 and
2 shownoHNprotein band(belowP, compare to lane0), as expected for
SeV-HNAFYKD (lane 1), and not surprisingly for a virus expressing
HNAFYKD+wt MeV-H. In lanes 3–5, however, a protein band just below
P was clearly visible, which we assumed at ﬁrst would be the MeV-H
protein. To our great surprise, this protein could not be precipitated
withα-MeV-H (Fig. 8B, IP, lanes 3–5) but was clearly precipitatedwith
α-SeV-HN (Fig. 8B, IP, lanes 3–5). It appears that the SeV-HN SYWST
motif, or the entire SeV-HN CD, or CD/TM domains (when present in
hybrid MeV-H proteins) are not sufﬁcient to allow incorporation of
these hybrid proteins into SeV particles. The presence of these hybrids
containing the SeV-HN SWYST motif, however, somehow eliminates
the restriction of SeV-HNAFYKD incorporation into SeV particles.
Discussion
SeV particle production does not require the incorporation of HN.
Infectious particle formation, however, does require the presence of
the cell surface receptor-binding protein, and HN uptake into SeV
particles requires a speciﬁc SYWST motif in its cytoplasmic tail. This
motif, while necessary, is not sufﬁcient, and this is clearly seen in the
study of the MeV-H protein variants. MeV-H variants in which the
entire cytoplasmic and trans-membrane domains (plus 80 amino acidsFig. 8. Expression of the MeV-H proteins in the context of rSeV-HNAFYKD infections. As in
Fig. 7, except that the SeV helper virus used to support the MeV-H minigenomes was the
rSeV-HNAFYKD allowing expression of the MeV-H proteins in the context of SeV-HNAFYKD
proteins. Antibodies to SeV-HN were used instead of SeV-N in Fig. 7.of the stemdomain, not shown)were substitutedwith those of HN and
were not incorporated into SeV particles. There appears, then, to be
further features of HN required for its selective uptake, presumably
present in the HN ectodomain (beyond the 80 amino acids proximal to
the membrane).
The SYWST motif is conserved at the same position in HPIV1 HN
cytoplasmic tail, even though these domains exhibit only 23% identity.
Moreover, a partly related 2EYWKH6 sequence is found in the
cytoplasmic tails of HPIV3 and BPIV3 HNs, even though these domains
exhibit only 15% identity with that of SeV. It is possible that the YW-
containing sequence in the cytoplasmic tails of all 4 respiroviruses
interact with a common cellular partner to promote formation of
infectious particle, but this remains to be investigated. In contrast to our
results with the MeV-H variants, the incorporation of the SWYST motif
within the cytoplasmic tail of NDV-HN appeared to be sufﬁcient for the
incorporation of the chimeric HN into SeV particles (Takimoto et al.,
1998).
All the MeV-H protein variants were expressed at the plasma
membrane, so that their exclusion from virus particles must take place
at a later stage in the assembly process. A previous study (Gosselin-
Grenet et al., 2006) showed that although HNAFYKD was excluded from
virus particles, it was found in detergent resistant membrane (DRM)
similar to HN. Thus, the selectivity in HN incorporation presumably
occurs after the gathering at DRM. The present study shows that
HNAFYKD, normally excluded fromvirus particles, is not internalized and
found in late endosomes like HN under these conditions. However, it is
unclear at this stage how the absence of HNAFYKD in late endosomes is
related to its failure to be incorporated into virus particles. The PIV5 HN
protein is also internalized from PM during infection, but the reason(s)
for this internalization are also unclear (Ng et al., 1990; Leser et al.,
1996).
As SeV-HN is internalized from the cell surface under conditions
where HNAFYKD is not, the SYWSTmotif is apparently also required for
internalization. At ﬁrst we thought that this internalization might
represent a necessary pathway to virus particle formation: i.e., a
further step required for the formation of the complete assembly
complex. However, the low fraction of internalizedHN incorporated in
virus particles (less than 20%) does not support this view. Rather, we
would like to propose that what is relevant in the internalization
process is the fraction (∼80%) that is not taken up in virus particles.
This fraction could serve the purpose of inactivating a putative
inhibitor of infectious particle formation, e.g., by removing it from
the plasma membrane where it would restrict HN incorporation into
virus particles. The notion that HN may have evolved a mechanism to
ensure infectious particle production by ﬁrst dealing with a cellular
“troublemaker” that could impair virus production is not novel. The
receptor-binding G protein of Ebola virus (another Mononegavirus),
for example, antagonizes Ebola VLPs production restriction by tetherin
(Kaletsky et al., 2009). Although this putative property of HN is purely
speculative, it is consistent with two important aspects of the
restriction of HN uptake; namely, (i) that this restriction is cell-type
dependent, and (ii) that the SYWSTmotif can act in trans to overcome
the restriction of HNAFYKD uptake, and permit its incorporation into
virus particles. This trans-complementation does not require the
incorporation of the SYWST-carrying-H proteins into virus particles;
these only appear to “pave the way”. This result is consistent with
further selective features of HN involved in its uptake.
These observations are hard to reconcile with the notion that a
fraction of HN (or another SWYST-carrying H protein) would recruit a
cellular partner that would help another subset of HN to be taken up in
virus particles. In contrast, they ﬁt better with the notion that an HN
fraction (or any SWYST-carrying H protein) could titrate a factor
preventing HN uptake. This factor would not be expressed equally
among different cell types, explaining the cell-type speciﬁcity of the
HNAFYKD phenotype. Further study of the SYWSTmotif, which can act in
trans to facilitate incorporation of theHN in SeVparticles,will hopefully
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cellular proteins interacting with HN cytoplasmic tails via SYWST need
to be searched. Classical yeast double-hybrid screens have so far failed
to identify any cellular partner that interactswith SeV-HN(P.O.Vidalain,
Pasteur Institute, Paris, personal communication). More appropriate
ﬁshing systems, like membrane double-hybrid systems, will hopefully
be more informative.
Finally, we have found that the two glycoproteins (HN and F)
appear as important as the matrix protein, if not more so, for the SeV
particle production. This is consistent with the major role of the
glycoproteins in the process as observed for PIV5 (Waning et al., 2002)
and inﬂuenza virus (Chen et al., 2007).
Materials and methods
Cells
All cells were grown at 37 °C under 5% CO2 atmosphere. LLCMK-2
cells were grown in Dulbecco modiﬁed Eagle's medium (DMEM)
supplemented with 5% fetal calf serum (FCS). LLCMK2-LV-siGFP cell
line [constitutively expressing a siRNA targeted to a green ﬂuorescent
protein sequence (gfpt)] and its corresponding control line LLCMK2-
LV-NGFR were prepared following the exact same protocol as the
one used to produce the corresponding A549 cell lines (described in
Mottet-Osman et al., 2007).
Viruses and infections
Production and description of recombinant Sendai virus (rSeV-HN,
previously denominated SeV-HNwt35) and rSeV-HNAFYKD (previously
denominated SeV-HNct35SIcp) have been reported before (Fouillot-
Coriou and Roux, 2000). The recombinant rSeV-M-gfpt, rSeV-F-gfpt,
rSeV-HN-gfpt, and rSeV-F/HN-gfpt were rescued as described previ-
ously for rSeV-Mgfpt (Mottet-Osman et al., 2007). Recombinantmixed
SeV virus stocks containing the minigenome SVec-CB119 expressing
the MeV-H proteins and its variants were rescued as described before
(Mottet et al., 1996), using as helper rSeV-HN or rSeV-HNAFYKD. Virus
stocks were prepared in 9-day-old embryonated eggs as described
(Fouillot-Coriou and Roux, 2000). For infection, the cells were rinsed
with DMEMdevoid of serumbefore addition of the virus, diluted in the
same medium. After 1 h of incubation at 33 °C, the infectious medium
was removed and replaced with fresh DMEM+2% FCS. Infected cells
were then incubated at 33 °C, unless otherwise speciﬁed. All virus
constructs, be it full-length genomes (+/− gfpt sequences) or
minigenomes, were designed so to conform to the rule of six (Calain
and Roux, 1993).
Cellular extracts and virus particle collection
Cells were harvested and disrupted in 300 μl of RIPA buffer
(150 mMNaCl, 1% deoxycholate, 1% triton X-100, 0.1% sodiumdodecyl
sulfate, 10 mM Tris–HCl, pH 7.4) containing 1% aprotinin and 20 mM
AEBSF as described before (Mottet et al., 1986). After 10 s of sonication
(Branson Sonic Sonifer B-12, lowest energy), cell extracts were spun
for 10 min at 12,000 rpm in a microfuge. The supernatants were then
processed for Western blotting analysis or for immune precipitation.
The virus particles were collected from the clariﬁed cell supernatants
by centrifugation through a 25% glycerol cushion (Beckman SW55
rotor, 2 h, 50,000 rpm, 4 °C) and directly resuspended in SDS sample
buffer for Western blotting analysis or disrupted in RIPA buffer and
processed for immune precipitation.
Antibodies
Antibodies used in this study include rabbit sera raised against
SeV SDS-denatured HN, F, N, or M proteins (α-HNSDS orα-FSDS,α-NSDS,α-MSDS), a mouse monoclonal antibody (MAb) anti-SeV M (MAb-383,
obtained from Claes Örvell, Laboratory of Clinical Virology, Huddinge
Hospital, Huddinge, Sweden), a MAb anti-Inﬂuenza virus HA epitope
(clone 16b12, Covance Research Products), a rat monoclonal
antibody (RtAb) anti-HA (clone 3F10, Roche), and a rabbit polyclonal
serum raised against the full-length GFP (RAb-GFP) protein (BD
Living ColorsTM Antibodies, Clontech Laboratories). The anti-MeV-H
antibody was purchased from Chemicon (cat. # MAB8905). The anti-
lysobisphosphatidic acid (LBPA) antibody was a gift from Jean
Grünberg (University of Geneva, Switzerland). Peroxidase-coupled
secondary antibodies were purchased from BioRad.
Plasmids
The plasmid pFl4-M-gfpt (harboring the full-length DNA copy of
the SeV genome) allowing the rescue of rSeV-Mgfpt, harboring a GFP
sequence (gfpt) [ﬂanked by two As and two Ts (5′-aaGAACGGCAT-
CAAGGTGAACtt-3′)] in the 5′ UTR of the M gene has been described
before (Mottet-Osman et al., 2007). The viruses rSeV-Fgfpt, -HN-gfpt,
and -HN/F-gfpt were rescued from pFl5 plasmids, a derivative of pFl4
described in Mottet-Osman et al. (2007). These plasmids were
obtained by insertion of gfpt in appropriate unique restriction sites
(Csp1, position 6254, for F and Not, position 8475, for HN). The MeV-H
gene plasmid was a gift from Roberto Cattaneo (Mayo Clinic, Rochester,
USA). The substitutions of the H-CD/TM domains with that of the SeV-
HNswere done by fusion PCR using appropriate PCR primers. TheMeV-
H genes were cloned into the SeV minigenomes SVec-CB119 as
described before (Mottet et al., 1996).
Surface protein biotinylation
Conﬂuent infected cells were infected and 20 h post-infection the
cells were put on ice to cool. They were then washed twice with ice-
cold PBS and then overlaid with 2 ml of Sulfo-NHS-SS-Biotin (Sigma),
at 0.3 mg/ml in cold PBS. After 15-min incubation at 4 °C, the cells
were rinsed once with Tris–HCl pH 8.0 and twice with ice-cold PBS.
De-biotinylation was performed by incubation in 50 mM DTT in PBS,
for 15 min at 4 °C. Further incubation was done in DMEM supple-
mented with 2% FCS at 4 °C or 37 °C.
Protein analysis
Western blot methodology was as described before (Mottet et al.,
1996), using the appropriate antibodies presented above. Protein
detection was performed using an enhanced chemiluminescence
system (Amersham Biosciences). The ﬁlms were scanned and the
band signals were quantiﬁed with One-Dscan program version 2.05,
Scanalytics. Biotinylated proteins were recovered by immobilized
streptavidin-agarose beads (Pierce) according to the supplier's
instructions. The recovered proteins were analyzed by Western
blots. Total cell or cell surface immune precipitations were performed
as described before (Mottet et al., 1986). Protein radio labeling was
performed as described (Gosselin-Grenet et al., 2007). 35S-labeled
viral proteins recovered by immune precipitations or constituting the
virus particle pellets were analyzed by SDS–PAGE electrophoresis and
processed for autoradiography as described before (Mottet et al.,
1986).
Immunoﬂuorescence imaging
Sterile coverslips, coated with poly-lysine (20 μg/ml, 1 h, 37 °C),
were seededwith cells at about8×104 cells/well, in Costar 24wells. The
next day, the cells were infected (moi=3) and further incubated at
33 °C. At 20 h post-infection, the cells were washed twice with PBS+
Ca+Mg (PBS+), and then ﬁxed with 4% para-formaldehyde by
incubation at room temperature for 15 min. Cells were then washed
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cells was achieved by incubation with a solution of PBS− containing
0.5% BSA and 0.1% saponine for 10 min at room temperature. Primary
antibodies were diluted in PBS− or in PBS–saponine buffer and added
to the ﬁxed cells for 1 h at room temperature. Secondary antibodies
were diluted in PBS–BSA and added for 30 min at room temperature.
Surface immunolabeling of intact cells was performed by incubation of
cells, previouslywashedwith PBS,with the primary antibody diluted in
cold PBS+ for 30 °C at 4 °C. For internalization observation, cells were
further incubated at 37 °C for increasing periods of time before ﬁxation.
In the end, coverslips were mounted in Mowiol 4-88 (Calbiochem,
475904). Observation was done either with Zeiss Axiovert ﬂuores-
cent microscope or with confocal microscope (LSM510, Carl Zeiss,
Oberkochen, Germany) equipped with oil immersion objectives (Plan-
Neoﬂuar 40×/1.3 and Plan-Apochromat 63×/1.4, Zeiss).
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